Table 1.
Distribution of AMD, DR, DME, and RVO among sexes in the cohort of patients
| Year | AMD group | DR group | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| F | M | TOT | F | M | TOT | ||||||||
| 2014 | 14 | 20 | 34 | 9 | 23 | 32 | |||||||
| 2015 | 47 | 37 | 84 | 28 | 48 | 76 | |||||||
| 2016 | 64 | 56 | 120 | 16 | 32 | 48 | |||||||
| 2017 | 68 | 71 | 139 | 7 | 20 | 27 | |||||||
| TOT | 193 | 184 | 377 | 60 | 123 | 183 | |||||||
| Year | DME group | RVO group | |||||||||||
| F | M | TOT | F | M | TOT | ||||||||
| 2014 | 0 | 0 | 0 | 8 | 12 | 20 | |||||||
| 2015 | 1 | 6 | 7 | 12 | 21 | 33 | |||||||
| 2016 | 17 | 42 | 59 | 21 | 19 | 40 | |||||||
| 2017 | 31 | 88 | 119 | 21 | 11 | 32 | |||||||
| TOT | 49 | 136 | 185 | 62 | 63 | 125 | |||||||
AMD: Age-related macular degeneration; DR: diabetic retinopathy; DME: diabetic macular oedema; RVO: retinal vein occlusion; F: female; M: male; TOT: total.